1. History of Rheumatic Diseases;
2. The musculoskeletal system;
3. Structural Molecules of the Connective Tissue;
4. The Role of Immune Mechanisms in the Pathogenesis of Rheumatic Disease;
5. Immunogenetics;
6. Molecular mechanisms underlying the expression of autoantibodies;
7. Inflammation mediators;
8. Patient Assessment;
9. Classification of Rheumatic Diseases;
10. Rheumatoid arthritis;
11. Systemic Lupus Erythematosus;
12. Antiphospholipid Syndrome;
13. Systemic Sclerosis and Related Syndromes;
14. Inflammatory and Metabolic Myopathies;
15. Sjogren's Syndrome;
16. Undifferentiated connective tissue syndromes;
17. Vasculitis;
18. Polymyalgia Rheumatica;
19. Recurrent polychondritis;
20. Seronegative spondyloarthropathies;
21. Rheumatic fever;
22. Pediatric Rheumatic Diseases;
23. Still's Disease in Adults;
24. Osteoarthritis;
25. Neuropathic arthropathy;
Infectious arthritis;
27. Lyme disease;
28. Sarcoidosis;
Behçet's syndrome;
30. Periodic Syndromes;
31. Gout;
32. Crystal Deposition Disease of Calcium Pyrophosphate Dihydrate;
33. Apatites and Crystals Miscellaneous;
34. Storage and deposition diseases;
35. Arthropathies Associated with Hematologic Diseases and Malignant Disorders;
36. Amyloidoses;
37. Neoplasms of Joints;
38. Arthropathies Associated with Endocrine Diseases;
39. Hyperlipoproteinemia and arthritis;
40. Musculoskeletal problems in patients on dialysis;
41. Fibromyalgia Syndrome;
42. Hereditary Connective Tissue Disorders;
43. Various Skin and Joint Joints;
44. AIDS and other immunodeficiency diseases;
45. Hypertrophic osteoarthropathy;
46. ​​Bone and Joint Dysplasias;
47. Disorders of the back and neck;
48. Osteonecrosis;
49. Paget's Bone Disease;
50. Regional rheumatic pain syndromes;
51. Reflex Sympathetic Dystrophy Syndrome and Transient Regional Osteoporosis;
52. Metabolic bone diseases;
53. Foreign Bone Synovitis;
54. Sports and Occupational Injuries;
55. Non-steroidal anti-inflammatory drugs and corticosteroids;
56. Slow-acting anti-rheumatic drugs and cytotoxic agents;
57. Biological Agents as New Potential Therapies for Autoimmune Diseases;
58. Therapeutic Injection of Joints and Soft Tissues;
59. Surgical treatment of arthritis;
60. Rehabilitation of patients with rheumatic diseases;
61. Psychosocial factors and arthritis;
62. The economic impact of arthritis:
63. Non-Traditional Remedies.